Cargando…
Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
Mutations in the breast cancer susceptibility 1 (BRCA1) gene are catalysts for breast and ovarian cancers. Most mutations are associated with the BRCA1 N- and C-terminal domains linked to DNA double-strand break (DSB) repair. However, little is known about the role of the intervening serine-glutamin...
Autores principales: | Beckta, Jason M., Dever, Seth M., Gnawali, Nisha, Khalil, Ashraf, Sule, Amrita, Golding, Sarah E., Rosenberg, Elizabeth, Narayanan, Aarthi, Kehn-Hall, Kylene, Xu, Bo, Povirk, Lawrence F., Valerie, Kristoffer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695017/ https://www.ncbi.nlm.nih.gov/pubmed/26320175 |
Ejemplares similares
-
Correction: Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining
por: Beckta, Jason M., et al.
Publicado: (2016) -
BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection
por: Guendel, Irene, et al.
Publicado: (2015) -
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres
por: Badie, Sophie, et al.
Publicado: (2015) -
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells
por: Dev, Harveer, et al.
Publicado: (2018) -
Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
por: Dever, Seth M., et al.
Publicado: (2011)